1984
DOI: 10.1111/j.1365-2125.1984.tb02372.x
|View full text |Cite
|
Sign up to set email alerts
|

A simple test for acetylator phenotype using caffeine.

Abstract: A method is presented for the use of caffeine, in the forms commonly ingested by a large proportion of the world's population, to test for the clinically important acetylation polymorphism. Each of 146 subjects provided a spot sample of urine between 2 and 6 h after coffee, tea or cola soft drink consumption, and the molar ratio of 5‐acetylamino‐6‐ formylamino −3‐methyluracil (AFMU) to 1‐methylxanthine (1X) was determined by a simple h.p.l.c. assay. The ratio afforded segregation of three apparent modes of ace… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
48
0
3

Year Published

1996
1996
2014
2014

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 186 publications
(52 citation statements)
references
References 16 publications
1
48
0
3
Order By: Relevance
“…Although less commonly reported, trimodal (rapid, intermediate and slow acetylator phenotype) distributions of N -acetylation capacity in vivo have been reported in humans following administrations of SMZ [21,22], isoniazid [23–26], sulfasalazine [27] and caffeine [28–29]. …”
Section: Discussionmentioning
confidence: 99%
“…Although less commonly reported, trimodal (rapid, intermediate and slow acetylator phenotype) distributions of N -acetylation capacity in vivo have been reported in humans following administrations of SMZ [21,22], isoniazid [23–26], sulfasalazine [27] and caffeine [28–29]. …”
Section: Discussionmentioning
confidence: 99%
“…Caffeine can be used as a non-toxic probe drug in vivo for predicting acetylator phenotype; by measuring metabolite ratio AFMU/1-methyl xanthine (1X) in urine after caffeine consumption, a bi- or tri-modal pattern in a given population is observed [39, 115, 151]. AFMU/AFMU+1X+1-methyluric acid (1U), AFMU+5-acetylamino-6-amino-3-methyluracil (AAMU)/AFMU+AAMU+1X+1U or AAMU/ AAMU+1X+1U metabolite ratios can also be used to determine acetylator phenotype [152156].…”
Section: Pharmacogeneticsmentioning
confidence: 99%
“…26 Designation of the acetylator (NAT2) phenotype was based on the ratio between 5-acetylamino-6-formylamino-3-methyluracil (AFMU) and 1-methylxanthine (1X). Results showed a clear bimodality of N-acetylation capacity with a ratio cut off point of 1.7 resulting in 61% slow and 39% fast acetylators.…”
Section: Ambient Exposure Measuresmentioning
confidence: 99%